Perspective Therapeutics (CATX) Receivables - Net (2011 - 2026)
Perspective Therapeutics (CATX) recorded Receivables - Net of $269,000 in Q2 2026, up 19.6% from $225,000 a year earlier and up 363.8% from the prior quarter.
Powered by 
Analysis
Perspective Therapeutics (CATX) Receivables - Net (2011 - 2026) Analysis & Trends
At the end of FY2025, Perspective Therapeutics reported Receivables - Net of $6,000, down 94.8% from FY2024.
- Annual Receivables - Net has declined for three straight years, with a five-year compound annual growth rate of -68.8% (FY2020 to FY2025).
- Across earlier years, Receivables - Net came in at $116,000 in FY2024 (-90.0%), $1.17 million in FY2023 (-14.5%), $1.36 million in FY2022 and $2.01 million in FY2021 (-1.5%).
- The Q2 2026 figure is the highest quarterly Receivables - Net since Q1 2024.
- On a year-over-year basis, Receivables - Net rose in two of the last eight quarters, with an average decline of 41.2%.
- Peak year-over-year performance for Receivables - Net in the last five years was growth of 58.5% in Q2 2025, against a decline of 94.8% in Q4 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $58,000 (Q1 2026), $6,000 (Q4 2025) and $179,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | Perspective Therapeutics | 298.91 Mn | 298.91 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 269,000.00 |
| Mar 31, 2026 | 58,000.00 |
| Dec 31, 2025 | 6,000.00 |
| Sep 30, 2025 | 179,000.00 |
| Jun 30, 2025 | 225,000.00 |
| Mar 31, 2025 | 78,000.00 |
| Dec 31, 2024 | 116,000.00 |
| Sep 30, 2024 | 217,000.00 |
| Jun 30, 2024 | 142,000.00 |
| Mar 31, 2024 | 999,000.00 |
| Dec 31, 2023 | 1.17 Mn |
| Sep 30, 2023 | 1.73 Mn |
| Jun 30, 2023 | 1.11 Mn |
| Mar 31, 2023 | 1.36 Mn |
| Dec 31, 2022 | 1.36 Mn |
| Sep 30, 2022 | 1.21 Mn |
| Jun 30, 2022 | 1.61 Mn |
| Mar 31, 2022 | 2.14 Mn |
| Dec 31, 2021 | 1.65 Mn |
| Sep 30, 2021 | 1.90 Mn |
API Access
Perspective Therapeutics Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=CATX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "CATX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=CATX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();